Greenway Medical Technologies Now Covered by Stephens (GWAY)
Investment analysts at Stephens assumed coverage on shares of Greenway Medical Technologies (NASDAQ:GWAY) in a note issued to investors on Tuesday, TheFlyOnTheWall.com reports. The firm set an “equal weight” rating on the stock.
Greenway Medical Technologies (NASDAQ:GWAY) opened at 15.94 on Tuesday. Greenway Medical Technologies has a 52-week low of $10.30 and a 52-week high of $19.65. The stock has a 50-day moving average of $12.6 and a 200-day moving average of $13.31. The company’s market cap is $474.3 million.
Greenway Medical Technologies (NASDAQ:GWAY) last posted its quarterly earnings results on Monday, August 19th. The company reported ($0.08) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.02) by $0.06. The company had revenue of $35.50 million for the quarter, compared to the consensus estimate of $34.04 million. During the same quarter in the previous year, the company posted $0.10 earnings per share. The company’s revenue for the quarter was down 2.3% on a year-over-year basis. On average, analysts predict that Greenway Medical Technologies will post $-0.02 earnings per share for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at KeyCorp initiated coverage on shares of Greenway Medical Technologies (NASDAQ:GWAY) in a research note to investors on Wednesday, September 4th. They set a “buy” rating on the stock. Separately, analysts at Sterne Agee reiterated a “sell” rating on shares of Greenway Medical Technologies (NASDAQ:GWAY) in a research note to investors on Tuesday, August 20th. They now have a $5.00 price target on the stock. Finally, analysts at Cowen and Company raised their price target on shares of Greenway Medical Technologies (NASDAQ:GWAY) from $11.00 to $15.00 in a research note to investors on Tuesday, August 20th. They now have a “market perform” rating on the stock.
Two research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $13.90.
Greenway Medical Technologies, Inc develops, markets and sells a suite of healthcare technology solutions, including practice management and electronic medical record software applications for physician practices, clinics and other providers in ambulatory settings.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.